Background: Fresh osteochondral allografts (OCAs) are limited in availability. The Missouri Osteochondral Allograft Preservation System (MOPS) has been reported to effectively preserve OCAs twice as long as current tissue bank protocols in preclinical studies.
Cartilage injuries typically lead to symptomatic osteoarthritis, which is the world's foremost orthopaedic disability and is predicted to affect more than 59.4 million Americans by 2020. 10 For knee osteoarthritis, unicompartmental and total knee arthroplasty are successful treatment options for older patients. 29, 42 However, in patients younger than 55 years, traditional artificial arthroplasty is not as successful based on complications, morbidity, level of activity, and likelihood for revision.
k Based on less successful outcomes after primary knee arthroplasty in conjunction with the diminishing outcomes associated with revision arthroplasty, patients younger than 55 years are not considered ideal candidates for traditional knee arthroplasty surgery.
Numerous treatment options have been developed to treat osteochondral lesions in younger patients, with microfracture or marrow stimulation, biological augmentation of marrow stimulation, autologous chondrocyte implantation, osteochondral autograft transplantation, and osteochondral allograft (OCA) transplantation being most commonly used. 11, 19, 20, 22, 27, 28, 38, 39 For larger lesions (.2.5 cm 2 ), marrow stimulation, biological augmentation of marrow stimulation, autologous chondrocyte implantation, and osteochondral autograft transplantation are associated with limitations and lower long-term success rates, while fresh OCA transplantation has been associated with an 88% return-to-sport rate and greater than 75% 10-year survival rate for the treatment of large femoral condyle lesions. 2, 12, [16] [17] [18] 29, 30, 37 The use of fresh OCAs in clinical practice is limited by the availability of acceptable donor tissue for eligible patients. One of the major limiting factors for OCA availability and use is the loss of essential chondrocyte viability during the preservation period after procurement and the need to discard insufficient OCAs before use. Based on previous studies, 6, 8, 12, 30, 32 the minimally sufficient chondrocyte viability for OCAs is considered to be 70% of the day 0 viable chondrocyte density (VCD), with successful outcomes strongly corresponding to this key metric for graft quality. The standard practice for tissue banks is to preserve OCAs in defined solutions at 4°C. Using these preservation methods, the mean VCD falls below the minimum essential level within 28 days after procurement. 3, 6, 8, 14, 24, 31, 40, 45 Because mandatory disease screening protocols typically take at least 14 days to complete before OCAs can be released for clinical use, the window for surgical implantation is narrow, which severely limits clinical use and results in the waste of donor tissue and in financial losses. Therefore, methods for OCA preservation that maintain essential chondrocyte viability for a longer period of time are a critical clinical need.
To address this need, the Missouri Osteochondral Allograft Preservation System (MOPS) was developed and validated. 6, 8, 9, 40 The MOPS protocol calls for the preservation of OCAs in a proprietary solution at room temperature (~25°C). It has been reported to maintain sufficient chondrocyte viability, articular cartilage extracellular matrix (ECM) composition, and material properties for at least 60 days after procurement and results in functional outcomes in a preclinical canine model. 8, 9 The present study was designed to evaluate the effectiveness of the MOPS protocol to maintain sufficient chondrocyte viability, ECM composition, and material properties in human femoral condyle OCAs. The hypotheses were that (1) the VCD (viable cells/tissue area in cm 2 ) in OCAs preserved for 28, 56, or 70 days using the MOPS protocol would not be significantly different from the day 0 level; (2) the VCD would be significantly higher in OCAs preserved using the MOPS protocol compared to OCAs preserved using current tissue bank protocols; and (3) media changes during preservation would be associated with significant improvements in the VCD in femoral condyle OCAs.
METHODS

OCA Harvest
Fresh femoral condyles were obtained from the Musculoskeletal Transplant Foundation (MTF). Femoral condyles (n = 24) were aseptically harvested from 1 knee of each qualified donor (n = 12) within 3 days of death using the MTF's standard collection protocol of OCA tissue for clinical use. Each femoral condyle from each donor was cut in half, resulting in quartered femoral condyles (n = 48). Each quarter condyle was assigned to a preservation protocol group described below and placed in 500 mL of MOPS solution (preservation media). Two osteochondral explants (1-2 g each) were included in each canister for sterility testing as described below. Additionally, to determine the effects of storage on tissue biomechanical properties, 8 mm-diameter osteochondral cylindrical explants were created from the femoral condyles of 12 donors (n = 36 explants), assigned to a preservation protocol group, and placed in 125 mL of MOPS preservation media.
OCA Preservation Protocol
Each quarter condyle was assigned to 1 of the 4 following preservation groups: preservation at 4°C without media change (4C-H), preservation at 25°C without media change (25C-H), preservation at 4°C with media change (4C-MC), and preservation at 25°C with media change (25C-MC).
For tissue in the groups with media change, the preservation media were aseptically changed every 7 days through a vacuum-driven filtration system using a 0.5-mm filter. Tissues were stored for 0, 28, 56, or 70 days, and 1 quarter condyle per donor at each time point (n = 3/group/time point) was tested for VCD, articular cartilage ECM composition (proteoglycan and collagen), and histological characteristics as described below. A media sample was collected at each preservation end point and used for sterility testing. For the 8-mm cylindrical explants, 1 explant per donor per time point (n = 3/group/ time point) was assessed for articular cartilage material properties as described below.
Sterility Testing
Designated media and tissue samples were collected from each tissue storage canister at the time of OCA evaluation (days 0, 28, 56, and 70). Two 10-mL preservation media samples and 2 osteochondral explant tissue samples were shipped overnight on wet ice to a qualified external contract laboratory for sterility testing according to the USP 71 protocol. 26 For media samples, two 5-mL samples were filtered through a 0.45-mm filter. After filtration, 1 filter was placed into 1500 mL of soybean-casein digest medium and cultured for 14 days at 20°C to 25°C. The other filter was placed into 1500 mL of fluid thioglycollate medium and cultured for 14 days at 30°C to 35°C. For the tissue sample, 1 tissue sample was placed into 1500 mL of soybean-casein digest medium and cultured for 14 days at 20°C to 25°C, and 1 tissue sample was placed into 1500 mL of fluid thioglycollate medium and cultured for 14 days at 30°C to 35°C. After 14 days, the cultured samples were examined for microbial growth, specifically for aerobic bacteria (Staphylococcus aureus, Bacillus subtilis, and Pseudomonas aeruginosa), anaerobic bacteria (Clostridium sporogenes), and fungi (Candida albicans and Aspergillus brasiliensis) based on clarity and appearance of the culture media. Sterility acceptance criteria were established based on a rating of negative or no growth. If a sample result was labeled positive, organism identification was to be initiated.
Chondrocyte Viability
For determination of the VCD, the quartered condyles were sectioned using a wet diamond band saw (Mar-Med). Three sections from each graft were stained in phosphate buffered saline containing the live cell stain calcein AM (1 mg/mL) and the dead stain SYTOX Blue (1.25 mM; Thermo Fisher Scientific) for 30 minutes at room temperature in a dark room. After staining, tissues were rinsed with phosphate buffered saline to remove excess stain, and full-thickness images of stained cartilage tissue were obtained at 43 using a BX51 fluorescence microscope (Olympus). Images were obtained using an F-View II 12-bit B&W CCD camera (Olympus). A minimum of 6 images from different regions of each section of the quarter condyle was obtained for analysis of the VCD. Viability was assessed subjectively for cell distribution through the depth of the tissue at each time point and objectively by determining the VCD. To quantify the VCD, the number of green-staining live cells was determined using an in-house cell counting program. 44 The area of the cartilage tissue section counted was measured using MicroSuite (Olympus), and the VCD was determined by dividing the number of green-staining viable cells by the area of the tissue (No. of viable cells/area of cartilage tissue in mm 2 ). For each quarter condyle, the VCD for all images was averaged to determine the final VCD for that quarter condyle OCA. After cell viability assessments, tissue sections were processed for histological evaluations and biochemical evaluations of the ECM composition.
Histological Evaluation
For histological assessments, tissues were fixed in 10% buffered formalin for at least 48 hours, decalcified in 10% EDTA, paraffin embedded, and stained with hematoxylin and eosin and Toluidine blue. Stained sections were evaluated using the Osteoarthritis Research Society International (OARSI) histological scoring system and scored by 2 board-certified veterinary pathologists blinded to treatment and time point. The OARSI system includes assessments of cartilage structure, chondrocyte appearance, proteoglycan distribution, collagen distribution, tidemark structure, and subchondral bone structure for a total potential pathological score of 60. 7 In this system, a higher score is indicative of more severe abnormalities. Two separate sections of each condyle were comprehensively scored, and the mean score for the 2 sections was used to provide a composite score of the sample for each pathologist. The mean scores for the 2 pathologists were used for data analyses.
Biomechanical Testing
For each explant tested, the thickness of the articular cartilage portion of the plug was measured using calipers. Measurements were taken at 4 locations around the circumference of the plug. An interpolation algorithm was implemented to approximate the cartilage thickness at the center of the explant based on the caliper measurements at the circumference. The explant was loaded into a custom unconfined testing well attached to the materials testing machine (Model 8821; Instron). The testing well was filled with culture fluid during testing and maintained at room temperature. Each explant was subjected to a stress relaxation test using a cylindrical indenter with a diameter of 4 mm, producing the force during compression and relaxation, time to maximum loading, and time-dependent behavior of the material. Samples were compressed to 80% of the original cartilage thickness (20% tissue strain) at a rate of 0.1 mm/s. The tissue was then held at a constant strain for 120 seconds. The data were then curve fit to determine the aggregate modulus and permeability. 34 
Statistical Analysis
To determine significant differences among groups, 1-way analysis of variance and post hoc testing were used with significance set at P \ .05.
RESULTS
Sterility Testing
All samples were negative for microbial growth on day 0. All samples from all groups stored at 4°C or 25°C, with or without media change, were negative for microbial growth at all time points when tested according to the USP 71 protocol, the standard used by the American Association of Tissue Banks (AATB).
Subjective Assessment of Chondrocyte Viability
Subjective assessments of the day 0 chondrocyte viability of tissue indicated that all quartered condyles had high viability at day 0, with viable chondrocytes present throughout all zones of the cartilage (Figure 1 ). Subjective assessments of day 28 storage samples indicated that chondrocyte viability in tissue samples stored at 4°C (4C-H, 4C-MC) had decreased considerably, with large areas of nonviable tissue, as identified by the paucity of live chondrocytes. However, tissue stored using the MOPS protocol at 25°C (25C-H, 25C-MC) consistently maintained chondrocyte viability throughout the tissue, with viable chondrocytes distributed from the superficial zone to the deep zone. Subjective assessments of day 56 storage samples indicated that chondrocyte viability in tissue stored at 4°C (4C-H, 4C-MC) continued to decrease considerably, with larger areas being devoid of live cells. Chondrocyte viability in tissue stored using the MOPS protocol at 25°C (25C-H, 25C-MC) consistently maintained chondrocyte viability throughout the cartilage. Subjective assessments of day 70 storage samples indicated that condyles stored at 4°C (4C-H, 4C-MC) had very few to no viable chondrocytes present. Condyles stored using the MOPS protocol at 25°C (25C-H, 25C-MC) had subjectively higher chondrocyte viability than those stored at 4°C. However, chondrocyte viability and distribution in these tissues did not consistently meet essential levels for all OCAs.
Viable Chondrocyte Density
The mean VCD on day 0 for all condyles combined (OCA sets 1-12) was 438. 2 . There were no statistically significant differences in the day 0 VCD among the groups (P = .27).
The VCDs of articular cartilage for the 4C-H and 4C-MC groups were significantly lower at day 28 (P .003), day 56 (P \ .001), and day 70 (P \ .001) compared to day 0. For condyles stored using the MOPS protocol at 25°C, there were no statistically significant differences in the VCD through day 56 of preservation with or without media change. In the 25C-H group, the VCDs at day 28 (P = .45), day 56 (P = .16), and day 70 (P = .14) were not significantly different from day 0. However, at day 70, VCD variability was notably larger than at other time points. The VCD in the 25C-MC group at day 28 (P = .88) and day 56 (P = .88) was not significantly different from day 0. However, at day 70, the VCD in the 25C-MC group was significantly (P = .002) lower than day 0.
The VCDs of quarter condyles preserved at 4°C were compared to those preserved using the MOPS protocol at 25°C at each time point. On days 28 (P = .003-.013) and 56 (P = .001-.002), the VCDs of condyles preserved using the MOPS protocol at 25°C with or without media change were significantly higher than condyles preserved at 4°C with or without media change. At day 70, quarter condyles preserved using the MOPS protocol at 25°C without media change (25C-H) had a significantly higher VCD compared to condyles preserved at 4°C with (P = .024) or without (P = .015) media change. However, the VCD of condyles preserved using the MOPS protocol at 25°C with media change (25C-MC) was not significantly (P = .08) different from those stored at 4°C with or without media change. There was not a significant difference among quarter condyles preserved using the MOPS protocol at 25°C with or without media change at any time point. Further, there was not a significant difference between quarter condyles preserved at 4°C with or without media change at any time point.
%VCD of Day 0 Grafts
For this study, the %VCD was determined by comparing the VCD for each quarter condyle at each time point to the mean VCD for all day 0 quarter condyles ( Figure 3) . 2 ) for the 4°C without media change (4C-H), 4°C with media change (4C-MC), 25°C without media change (25C-H), and 25°C with media change (25C-MC) groups at day 0, day 28, day 56, and day 70 of storage. *Significantly (P \ .05) lower than the mean of all day 0 samples.
In the 4C-H group, the %VCD decreased significantly (P = .011) to below the minimum essential level by day 28 (50.7%; 95% CI, 23.2% to 78.1%) and continued to decrease through day 56 (25.8%; 95% CI, -20.9% to 72.6%) and day 70 (15.4%; 95% CI, -29.7% to 60.6%). Media changes at 4°C did not improve maintenance of the VCD, and the %VCD in the 4C-MC group decreased significantly (P \ .001) to below the minimum essential level by day 28 (52.4%; 95% CI, 32.4% to 72.3%) and continued to decrease through day 56 (25.3%; 95% CI, -0.6% to 51.2%) and day 70 (8.8%; 95% CI, -6.5% to 24.0%).
In grafts stored using the MOPS protocol at 25°C, the mean %VCD of the 25C-H group was maintained above the minimum essential level at day 28 (102.9%; 95% CI, 94.1%-111.7%), day 56 (89.2%; 95% CI, 77.2%-101.1%), and day 70 (73.9%; 95% CI, 11.4%-136.4%) and was not significantly decreased (P . .14) from day 0 at any time point. In the 25C-MC group, the mean %VCD was maintained above the minimum essential level at day 28 (95.4%; 95% CI, 82.1%-108.8%) and day 56 (98.6%; 95% CI, 87.7%-109.5%) and was not significantly lower (P . .86) than day 0 at either time point. However, at day 70 (46.8%; 95% CI, -7.0% to 100.6%), the %VCD in the 25C-MC group was significantly lower (P = .001) than day 0 and below the minimum essential level of 70%.
Histological Evaluation
Histological assessments of tissue architecture using the OARSI system were performed by 2 board-certified pathologists who were blinded to treatment and time point. There were no to little histopathological changes noted with no significant differences (P . .05) among the groups for day 0 scores, indicating that healthy condyles were obtained for this study (Figure 4 ). There were no significant (P . .05) differences in histological scores for any groups at any time point when compared to day 0. Further, there were no significant (P . .05) differences in histological scores among the groups (4C-H, 4C-MC, 25C-H, 25C-MC) at days 28, 56, or 70 of preservation. These data indicate that the preservation of quarter condyles at 4°C and 25°C did not result in significant histological changes in the OCAs through 70 days.
Biomechanical Properties
To account for inherent patient-to-patient variability, day 0 samples in each group (4C-H, 4C-MC, 25C-H, 25C-MC) were used for statistical comparisons of material properties within the groups over time. Based on this analysis, there were no statistically significant (P . .05) differences in the aggregate modulus or tissue permeability for any group at any time point analyzed (Table 1 ). These data indicate that, in agreement with the tissue histological analysis, the biomechanical properties of OCA cartilage tissue did not degrade during storage.
DISCUSSION
The data from this study indicate that the MOPS protocol maintained essential viability of femoral condyle OCAs through at least 56 days of preservation after procurement. In fact, the VCD was maintained at nearly 90% of day 0 values through 56 days of MOPS preservation with or without media change. Importantly, viable chondrocytes were present throughout the entirety of the articular cartilage from the surface to the deep zone of MOPS-preserved OCAs, and histological and biomechanical assessments confirmed the maintenance of ECM morphology and composition as well as OCA material properties and asepsis. By day 70 of preservation, the mean %VCD in MOPS-preserved OCAs without media change was nearly 74% of day 0, with 66% falling below the essential level by this time point. MOPS-preserved OCAs with media change all fell below the sufficient level by day 70 of preservation, suggesting that media changes are not beneficial for the maintenance of chondrocyte viability. OCAs stored using standard tissue bank protocols at 4°C fell to a mean %VCD that was below the essential level by 28 days of preservation, which matches previously published data, 2, 3, 13, [16] [17] [18] 22, 39 and were well below the essential level at days 56 and 70 after procurement.
Based on the longstanding and growing body of literature reporting the critical importance of donor chondrocyte viability for successful outcomes after OCA transplantation, 6, 8, 12, 30, 32 the results of the present work provide pivotal data for surgeons, scientists, and tissue banks involved in this field of study. The documented capabilities for MOPS-preserved OCAs to maintain more than sufficient chondrocyte viability, ECM composition, and biomechanical properties for at least 56 days after procurement allow us to accept our first 2 hypotheses and provide a potential means for improving outcomes in patients. MOPS preservation appears to allow the maintenance of OCA quality at higher levels and for a much longer period of time than current tissue bank protocols. These improvements allow surgeons to have increased confidence in the quality of grafts that they are transplanting and provide tissue banks with a much longer period of time for matching and delivering OCAs for patient use. This results in decreased tissue waste and related financial costs.
The data from the present study, however, require that we reject our third hypothesis in that media changes during preservation were not associated with significant improvements in the VCD. This is a surprising but advantageous finding in that the authors anticipated refreshed media would better maintain OCA quality during prolonged preservation but, if true, would likely require repeat sterility testing after each media change, making implementation for clinical use no longer feasible. Because the MOPS protocol did not require media changes to preserve OCA quality, clinical implementation is feasible. The improved VCD in OCAs preserved beyond 56 days in the MOPS without media changes is thought to be related to the physiology of normal articular cartilage. Because of the avascular nature of articular cartilage, the tissue exists in a low oxygen tension environment with a relatively low level of metabolic activity. 23, 41, 43 Therefore, by not refreshing the storage media and keeping the container sealed, the preservation environment of the OCA may be more similar to that of native articular cartilage, resulting in a more physiological metabolism. Ongoing studies in our laboratory are aimed at delineating the mechanisms that result in these important benefits.
A concern for OCA storage at temperatures above 4°C is the perceived increased risk for microbial contamination and persistence during preservation. In the present study, all tissues and media samples from all groups and time points passed stringent sterility testing, and no microbial growth was detected by an outside laboratory dedicated to sterility testing according to the USP 71 protocol. 26 These data indicate that OCA preservation at room temperature (25°C) does not increase the potential risk for microbial contamination and persistence compared to current tissue bank protocols at 4°C. These data are in agreement with previous preclinical studies and validate the safety of the long-term storage of OCAs using the MOPS protocol at room temperature (25°C) for subsequent clinical implantation. 8, 9, 40 Another concern for OCA storage at temperatures above 4°C is the potential loss of tissue ECM architecture and composition. The data from this study indicate that longterm storage of OCAs did not significantly affect OCA architecture and composition when stored using the MOPS protocol at room temperature. There were no significant changes in the MOPS-preserved OCA material properties more than 70 days from procurement. Further, histological assessments showed the maintenance of cell morphology, ECM staining for proteoglycan and collagen, and articular surface integrity throughout the study period. These data are in agreement with all previously reported studies, which have suggested that the ECM is maintained for this duration of graft storage even when chondrocyte viability falls below essential levels. 1, 31 This highlights the importance of assessing chondrocyte viability for OCAs, and it provides further evidence for the use of OCAs stored at 25°C using the MOPS protocol without media changes for clinical implantation through 56 days of storage.
The data from this and previous studies indicate that the ECM of OCA cartilage tissue does not appreciably degrade during storage across a range of temperatures and conditions. 1, 31 Because the articular cartilage ECM is degraded through biomechanical loading and degradative enzymes in vivo, it is likely that the amelioration of both of these processes during storage protects the ECM. OCAs are not loaded during storage, and matrix metalloproteinases and aggrecanases, the 2 classes of degradative enzymes primarily responsible for ECM degradation, are highly regulated in normal articular cartilage. 5, 15 Because the tissues used for OCAs are normal and stored in a chondroprotective environment, it is likely that degradative enzymes remain tightly controlled. Further, because the tissues are stored at temperatures lower than body temperature, the metabolic activity of the chondrocytes is reduced, potentially further decreasing the production and/or activity of these degradative enzymes. This combination of factors can explain the consistent lack of a detectable loss of the OCA ECM during storage. The relatively low oxygen tension associated with the MOPS may help to further regulate factors such as oxygen-free radicals, matrix metalloproteinases, and aggrecanases that govern chondrocyte health and tissue degradation to maintain the ECM for the longer duration of storage assessed in the present study. Ongoing studies in our laboratory are aimed at further delineating the mechanisms behind these important findings.
The limitations of the present study include the sample size, the number of preservation media evaluated, and the single tissue type included. While only 3 samples per time point were included in each of the 4 test groups, comprehensive analyses were performed on each, and statistically significant differences were noted; this validates the key findings reported. Only one preservation media type was evaluated rather than all of the slight variations in solutions among tissue banks to minimize confounding variables and effectively test the study hypotheses. Based on United States Food and Drug Administration and AATB requirements, variations among preservation media are small, suggesting that the results of the present study can be applied to each of the current tissue bank protocols. Only femoral condyles were assessed, which was based on the most common clinical use and tissue availability. While this precludes direct conclusions regarding differences in preservation protocols for other OCA tissues, current tissue bank protocols and peer-reviewed literature suggest that extrapolation is reasonable.
The results of the present study allow us to conclude that the MOPS at room temperature (25°C) preserved OCA quality at significantly higher levels than standard tissue bank protocols in refrigeration (4°C). MOPSpreserved OCAs maintained day 0 VCD levels for at least 56 days after procurement without media changes, conserved ECM morphology and composition, and sustained tissue biomechanical properties without increasing the risk for sterility testing failure. These improvements in the viability and duration of OCA preservation associated with the MOPS engender potential benefits to tissue banks, donor families, surgeons, and patients with respect to tissue use, financial costs, and outcomes.
